You decide to complete a summer undergraduate research project in a lab that studies G-Protein coupled receptor (GPCR) signaling. The laboratory you join has identified two new GPCRs, GPCR-A and GPCR-B. The same ligand binds each receptor, but two different heterotrimeric G-proteins are activated that regulate adenylyl cyclase. A. You find that activation of GPCR-A causes an increase in adenylyl cyclase activity, while activation of GPCR-B causes a decrease in adenylyl cyclase activity.
B. You have a cell line that expresses both GPCR-A, GPCR-B, the corresponding G proteins and adenylyl cyclase. There is a basal level of adenylyl cyclase activity that produces a baseline cAMP concentration. Your project is to characterize a series of mutations in these components. Will each mutation increase or decrease the intracellular levels of cAMP upon ligand addition (remember, both GPCR-A and GPCR-B bind the same ligand)?
a. A mutation in GPCR-A that prevents G-protein activation
b. A mutation in GPCR-B that prevents G protein activation
c. A mutation in Gsa that prevents release of bound GDP
d. A mutation in Gia that prevents GTP hydrolysis
EXPLAIN your thought process and why each one was answered as increase or decrease
You decide to complete a summer undergraduate research project in a lab that studies G-Protein coupled receptor (GPCR) signaling. The laboratory you join has identified two new GPCRs, GPCR-A and GPCR-B. The same ligand binds each receptor, but two different heterotrimeric G-proteins are activated that regulate adenylyl cyclase. A. You find that activation of GPCR-A causes an increase in adenylyl cyclase activity, while activation of GPCR-B causes a decrease in adenylyl cyclase activity.
B. You have a cell line that expresses both GPCR-A, GPCR-B, the corresponding G proteins and adenylyl cyclase. There is a basal level of adenylyl cyclase activity that produces a baseline cAMP concentration. Your project is to characterize a series of mutations in these components. Will each mutation increase or decrease the intracellular levels of cAMP upon ligand addition (remember, both GPCR-A and GPCR-B bind the same ligand)?
a. A mutation in GPCR-A that prevents G-protein activation
b. A mutation in GPCR-B that prevents G protein activation
c. A mutation in Gsa that prevents release of bound GDP
d. A mutation in Gia that prevents GTP hydrolysis
EXPLAIN your thought process and why each one was answered as increase or decrease
For unlimited access to Homework Help, a Homework+ subscription is required.
Related textbook solutions
Related questions
QUESTION 1
Which of the following is an example of an extracellular signal molecule?
a. | IP3 | |
b. | cAMP | |
c. | Insulin | |
d. | Diacylglycerol |
2 points
QUESTION 2
Nuclear hormone receptors _____
a. | Bind to water soluble ligands | |
b. | Activate second messengers | |
c. | Regulate transcription in response to ligand binding | |
d. | Are normally located on the plasma membrane |
2 points
QUESTION 3
Which of the following does not occur when a receptor tyrosine kinase is bound by ligand?
a. | Phosphorylation of the RTK | |
b. | Cytoplasmic proteins bind the phosphorylated RTK | |
c. | Dimerization of the RTK | |
d. | The RTK binds to DNA to regulate transcription |
2 points
QUESTION 4
Which of these is a logical signal-transduction pathway?
a. | An intracellular receptor activates phospholipase C, which cleaves a membrane protein to form IP3, which then activates the opening of an ER channel protein, which releases cyclic AMP into the cytoplasm, where it binds to an intracellular enzyme that carries out a response. | |
b. | A G-protein-linked receptor activates G protein, which activates phospholipase C, which cleaves a membrane lipid to form IP3, which binds to a calcium channel on the ER, which opens to release calcium ions into the cytoplasm, which bind to an intracellular enzyme that carries out a response. | |
c. | An ion-channel receptor opens, allowing a steroid hormone to enter the cell; the steroid hormone then activates protein kinases that convert GTP to GDP, which binds to an intracellular enzyme that carries out a response. | |
d. | A tyrosine-kinase receptor activates adenylyl cyclase, which activates phospholipase C, which converts ATP into cyclic AMP, which binds to an intracellular enzyme that carries out a response. |
2 points
QUESTION 5
Which of the following is an example of signal amplification?
a. | activation of an enzyme molecule | |
b. | activation of a specific gene by a growth factor | |
c. | Breakdown of many cAMP molecules | |
d. | activation of 100 molecules by a single signal binding event |
2 points
QUESTION 6
Consider a signal transduction pathway that utilizes cAMP as a second messenger to activate PKA (Protein Kinase A). Which of the following situations will result in the cellular response?
The G protein releases GDP and binds to GTP | ||
The target protein (adenylyl cyclase) is inactive | ||
The regulatory subunits of PKA (Protein Kinase A) are bound to the catalytic subunits | ||
The appropriate G protein is bound to GDP |
2 points
QUESTION 7
Which of the following is found in only some signal transduction pathways? [In other words, which is not found in all signal transduction pathways?]
Receptor protein | ||
Extracellular signal molecule | ||
Intracellular signaling molecule | ||
Cellular response | ||
Effector protein |
2 points
QUESTION 8
The enzyme that specifically catalyzes the conversion of ATP to cAMP is:
Adenylyl phosphatase | ||
Adenylyl kinase | ||
Adenylyl dehydrogenase | ||
Adenylyl cyclase |
2 points
QUESTION 9
If an animal cell suddenly lost the ability to produce GTP, what might happen to its signaling system?
It would use ATP instead of GTP to activate and inactivate the G protein on the cytoplasmic side of the plasma membrane. | ||
It would not be able to activate and inactivate the G protein on the cytoplasmic side of the plasma membrane. | ||
It would employ a transduction pathway directly from an external messenger. | ||
It would be able to carry out reception and transduction but would not be able to respond to a signal. |
2 points
QUESTION 10
A hormone signal is sent from the brain to other parts of the body via the bloodstream. Why do only certain cells respond to this signal?
Hormones do not last long enough in the bloodstream to stimulate a cellular response | ||
Only cells that have a specific transcription factor gene will be able to respond to the signal | ||
Only cells in the immediate vicinity of the cell sending the signal will respond | ||
Only cells that have a receptor for the specific signal will be able to respond to it |
Part A
The ultimate problem with cholera that can lead to death is __________.
The ultimate problem with cholera that can lead to death is __________.
only water loss |
fluid loss with electrolyte concentrations remaining normal |
severe dehydration and electrolyte imbalance |
only electrolyte loss |
SubmitMy AnswersGive Up
Part B
The loss of chloride ions is occurring as a result of an continuously open __________, found in certain intestinal epithelial cells.
The loss of chloride ions is occurring as a result of an continuously open __________, found in certain intestinal epithelial cells.
chloride channel protein |
sodium pump |
ATP dependent sodium/potassium pump |
potassium pump |
SubmitMy AnswersGive Up
Part C
The main purpose of the chloride channel proteins on the apical surface of the intestinal epithelial cells is to create an osmotic gradient that ultimately causes __________ to move through the intestinal epithelium and into the intestinal lumen to assist in the formation of mucus. These are the same chloride channel proteins, adversely affected in cystic fibrosis.
The main purpose of the chloride channel proteins on the apical surface of the intestinal epithelial cells is to create an osmotic gradient that ultimately causes __________ to move through the intestinal epithelium and into the intestinal lumen to assist in the formation of mucus. These are the same chloride channel proteins, adversely affected in cystic fibrosis.
potassium |
calcium |
water |
sodium |
SubmitMy AnswersGive Up
Part D
The main physiologic mechanism used to control the opening of the chloride channel protein is through the use of __________.
The main physiologic mechanism used to control the opening of the chloride channel protein is through the use of __________.
G proteinâlinked receptors |
potassium pump |
enzyme-linked receptors |
sodium pump |
SubmitMy AnswersGive Up
Part E
The main factor that causes cholera is the overstimulation of __________ by the __________.
The main factor that causes cholera is the overstimulation of __________ by the __________.
guanylate cyclase; the bacterium Vibrio cholerae |
adenylate cyclase; the bacterium Vibrio cholerae |
guanylate cyclase; cholera toxin |
adenylate cyclase; cholera toxin |
SubmitMy AnswersGive Up
Part F
The normal physiologic mechanism used by G proteinâlinked receptors is for a ligand to bind to the G proteinâlinked receptor; this in turn activates __________ located in the intracellular side of the plasma membrane, which eventually leads to the physiologic effector action.
The normal physiologic mechanism used by G proteinâlinked receptors is for a ligand to bind to the G proteinâlinked receptor; this in turn activates __________ located in the intracellular side of the plasma membrane, which eventually leads to the physiologic effector action.
diacylglycerol |
inositol triphosphate |
G protein |
cyclic AMP |
SubmitMy AnswersGive Up
Part G
Cholera toxin bypasses the normal sequential cascade of events involving G protein activation. The __________subunit of cholera toxin enters into the cell and directly activates __________. This leads to a non-physiologic (non-homeostatic) action of inappropriately maintaining the chloride channel proteins open. This causes excessive __________, sodium, and water to leave the intestinal epithelial cells.
Cholera toxin bypasses the normal sequential cascade of events involving G protein activation. The __________subunit of cholera toxin enters into the cell and directly activates __________. This leads to a non-physiologic (non-homeostatic) action of inappropriately maintaining the chloride channel proteins open. This causes excessive __________, sodium, and water to leave the intestinal epithelial cells.
A; G protein; chloride |
B; G protein; chloride |
B; inositol triphosphate; calcium |
A; diacylglycerol; chloride |
SubmitMy AnswersGive Up
Part H
A defect in the chloride channel protein, causing it to not open, will _________ the chloride, sodium, and water loss in cholera. However, it will also cause the individual to have __________ mucus.
A defect in the chloride channel protein, causing it to not open, will _________ the chloride, sodium, and water loss in cholera. However, it will also cause the individual to have __________ mucus.
allow; thick |
allow; thin |
prevent, thin |
prevent; thick |
SubmitMy AnswersGive Up
Part I
A drug that prevents the cholera toxin from attaching to the __________ in the intestinal epithelial cell could be a useful treatment.
A drug that prevents the cholera toxin from attaching to the __________ in the intestinal epithelial cell could be a useful treatment.
ganglioside |
protein |
phospholipid |
AMP |
SubmitMy AnswersGive Up
Part J
The best method to reduce the spread of cholera is to __________.
The best method to reduce the spread of cholera is to __________.
never travel to underdeveloped countries |
provide properly treated water supplies |
give everyone antibiotics |
give everyone antacids |
Need help with biology questions:
1. To increase the excretion of an acidic drug, what would you do to the urine?
A. | Make it more basic | |
B. | None of the above | |
C. | Make it neutral | |
D. | Make it more acidic |
2. G-Protein coupled receptors directly act on which of the following secondary messenger molecules:
A. | cAMP | |
B. | ATP | |
C. | ADP | |
D. | GTP | |
E. | None of the above or more than one of the above |
3. Drug A and Drug B both produce the same level of biological/physiological response. Drug A produces this effect with 100 mg/kg dose. Drug B produces this effect with 50 mg/kg dose. Which of the following is true?:
A. | Drug B is more efficacious than Drug A. Both drugs are equally potent. | |
B. | Drug A is more efficacious than Drug B. Both drugs are equally potent. | |
C. | Drug A and B are equally efficacious. Drug A is more potent than Drug B. | |
D. | Drug A and B are equally efficacious. Drug B is more potent than Drug A. |
4. The stomach has a ______ pH, whereas the small intestines have a _______ pH. The colon has an approximately ___________ pH.
A. | High; low; neutral | |
B. | Low; high; neutral | |
C. | Low; neutral; neutral | |
D. | None of the above |
5. Which receptor is most likely to reduce norepinephrine levels when activated?
A. | alpha 2 adrenergic | |
B. | alpha 1 adrenergic | |
C. | dopamine D1 receptors |
6. Which of the following statements are FALSE?
A. | If the Vd of a drug is between 60 and 80 L the drug has likely distributed to the total body water of a 200 kg man. | |
B. | In the enterohepatic system the activity of bacteria to remove conjugates from a drug in the gut will decrease the clearance of the drug. | |
C. | Lipid drugs are more likely to be reabsorbed by the kidney from the urine. | |
D. | A weak basic drug (pKa = 6) will be mostly ionized in urine of a pH= 3 and only the non- ionized drug will be eliminated. | |
E. | The major conjugate in Phase 2 metabolism is glucuronide. |
7. Isoproterenol (β-agonist) is a vasodilator that increases HR. What happens to systolic and diastolic pressures upon IV administration of isoproterenol?
A. | â systolic; â diastolic | |
B. | â systolic; â diastolic | |
C. | â systolic; â diastolic | |
D. | â systolic; â diastolic | |
E. | None of the above |
8. If you want to increase the blood concentration of a drug A, you can perform which of the following procedures:
A. | Inhibit Drug A metabolism with Drug B | |
B. | Enhance Drug A reabsorption from renal proximal tubule by changing ionization of Drug A with Drug B | |
C. | Allow competition of Drug B with Drug A for active renal secretion processes | |
D. | Increase the binding of Drug A to serum albumin | |
E. | All of the above |
9. Which of the following describes Phase I metabolism?
A. | Inactive products are always produced in this phase. | |
B. | Large molecules such as glucuronic acid are conjugated to drugs in this phase. | |
C. | This phase may produce active metabolites from prodrugs. | |
D. | This phase only occurs in the liver. |
10. Which of the following is NOT an enzyme involved in the biosynthesis of biogenic amines?
A. | Phenylethanolamine N-methyl Transferase | |
B. | Dopamine β-hydroxylase | |
C. | Tyrosine dehydroxylase | |
D. | DOPA decarboxylase | |
E. | All of the above |
11. Why would an antibiotic at the same concentration be more active against bacteria in water than in serum or plasma? (Activity is measured in a test tube)
A. | activity of the antibiotic is increased in water. | |
B. | due to drug-protein interaction in serum | |
C. | the antibiotic is more stable in water | |
D. | all of the above | |
E. | none of the above |
12. Ion channels are targets for drugs. Which drug class targets Na+ channels?
A. | Benzodiazepines | |
B. | Beta blockers | |
C. | Local anesthetics | |
D. | Antihypertensive drugs (cardiac and smooth muscle) | |
E. | Glibenclimide (diabetic drug) |
13. _________________ not metabolized by catechol-O-methyltransferase (COMT).
A. | Dopamine | |
B. | Epinephrine | |
C. | Phenylephrine | |
D. | Norepinephrine | |
E. | All of the above are metabolized by COMT. |